Shopping Cart 0
Cart Subtotal
AED 0

Pavmed Inc (PAVM) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed's product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pavmed Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Pavmed Inc Company Overview

Pavmed Inc Company Snapshot

Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview

Pavmed Inc-Pipeline Analysis Overview

Pavmed Inc-Key Facts

Pavmed Inc-Major Products and Services

Pavmed Inc Pipeline Products by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc Pipeline Products Overview

Caldus-Renal Denervation

Caldus-Renal Denervation Product Overview

Caldus-Traditional Tissue Ablation

Caldus-Traditional Tissue Ablation Product Overview

CarpX

CarpX Product Overview

CarpX Clinical Trial

DisappEAR

DisappEAR Product Overview

NextCath

NextCath Product Overview

NextFlo

NextFlo Product Overview

PortIO

PortIO Product Overview

PortIO Device-Next Generation

PortIO Device-Next Generation Product Overview

Pavmed Inc-Key Competitors

Pavmed Inc-Key Employees

Pavmed Inc-Locations And Subsidiaries

Head Office

Recent Developments

Pavmed Inc, Recent Developments

May 21, 2019: PAVmed reports first quarter 2019 financial results and provides business update

May 20, 2019: PAVmed announces first human CarpX procedures

Apr 24, 2019: PAVmed reports excellent DisappEAR animal study results

Apr 04, 2019: PAVmed reports fourth quarter 2018 financial results and provides business update

Mar 20, 2019: PAVmed announces NextFlo breakthrough

Mar 13, 2019: PAVmed announces PortIO breakthrough

Aug 14, 2018: Pavmed announces second quarter 2018 financial results

Jul 25, 2018: Pavmed provides business update

Jul 11, 2018: PAVmed Appoints Shaun O'Neil Chief Commercial Officer

Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Pavmed Inc Pipeline Products by Equipment Type

Pavmed Inc Pipeline Products by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview

Pavmed Inc Pipeline Products by Equipment Type

Pavmed Inc Pipeline Products by Indication

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc, Key Facts

Pavmed Inc, Major Products and Services

Pavmed Inc Number of Pipeline Products by Development Stage

Pavmed Inc Pipeline Products Summary by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc Ongoing Clinical Trials Summary

Caldus-Renal Denervation-Product Status

Caldus-Renal Denervation-Product Description

Caldus-Traditional Tissue Ablation-Product Status

Caldus-Traditional Tissue Ablation-Product Description

CarpX-Product Status

CarpX-Product Description

CarpX-Prospective, Single-center, Single Arm, Feasibility Study of the PAVmed CarpX Device for the Treatment of Carpal Tunnel Syndrome

DisappEAR-Product Status

DisappEAR-Product Description

NextCath-Product Status

NextCath-Product Description

NextFlo-Product Status

NextFlo-Product Description

PortIO-Product Status

PortIO-Product Description

PortIO Device-Next Generation-Product Status

PortIO Device-Next Generation-Product Description

Pavmed Inc, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Pavmed Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

SINTX Technologies Inc

Atossa Genetics Inc

Advanced BioMedical Technologies, Inc.

Company Profile

Company Profile Title

Summary

Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed's product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pavmed Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Pavmed Inc Company Overview

Pavmed Inc Company Snapshot

Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview

Pavmed Inc-Pipeline Analysis Overview

Pavmed Inc-Key Facts

Pavmed Inc-Major Products and Services

Pavmed Inc Pipeline Products by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc Pipeline Products Overview

Caldus-Renal Denervation

Caldus-Renal Denervation Product Overview

Caldus-Traditional Tissue Ablation

Caldus-Traditional Tissue Ablation Product Overview

CarpX

CarpX Product Overview

CarpX Clinical Trial

DisappEAR

DisappEAR Product Overview

NextCath

NextCath Product Overview

NextFlo

NextFlo Product Overview

PortIO

PortIO Product Overview

PortIO Device-Next Generation

PortIO Device-Next Generation Product Overview

Pavmed Inc-Key Competitors

Pavmed Inc-Key Employees

Pavmed Inc-Locations And Subsidiaries

Head Office

Recent Developments

Pavmed Inc, Recent Developments

May 21, 2019: PAVmed reports first quarter 2019 financial results and provides business update

May 20, 2019: PAVmed announces first human CarpX procedures

Apr 24, 2019: PAVmed reports excellent DisappEAR animal study results

Apr 04, 2019: PAVmed reports fourth quarter 2018 financial results and provides business update

Mar 20, 2019: PAVmed announces NextFlo breakthrough

Mar 13, 2019: PAVmed announces PortIO breakthrough

Aug 14, 2018: Pavmed announces second quarter 2018 financial results

Jul 25, 2018: Pavmed provides business update

Jul 11, 2018: PAVmed Appoints Shaun O'Neil Chief Commercial Officer

Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Pavmed Inc Pipeline Products by Equipment Type

Pavmed Inc Pipeline Products by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview

Pavmed Inc Pipeline Products by Equipment Type

Pavmed Inc Pipeline Products by Indication

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc, Key Facts

Pavmed Inc, Major Products and Services

Pavmed Inc Number of Pipeline Products by Development Stage

Pavmed Inc Pipeline Products Summary by Development Stage

Pavmed Inc Ongoing Clinical Trials by Trial Status

Pavmed Inc Ongoing Clinical Trials Summary

Caldus-Renal Denervation-Product Status

Caldus-Renal Denervation-Product Description

Caldus-Traditional Tissue Ablation-Product Status

Caldus-Traditional Tissue Ablation-Product Description

CarpX-Product Status

CarpX-Product Description

CarpX-Prospective, Single-center, Single Arm, Feasibility Study of the PAVmed CarpX Device for the Treatment of Carpal Tunnel Syndrome

DisappEAR-Product Status

DisappEAR-Product Description

NextCath-Product Status

NextCath-Product Description

NextFlo-Product Status

NextFlo-Product Description

PortIO-Product Status

PortIO-Product Description

PortIO Device-Next Generation-Product Status

PortIO Device-Next Generation-Product Description

Pavmed Inc, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Pavmed Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

SINTX Technologies Inc

Atossa Genetics Inc

Advanced BioMedical Technologies, Inc.